Skip to main content
. 2019 Dec 30;15(4):397–415. doi: 10.1016/j.ajps.2019.11.004

Fig. 6.

Fig 6

Fabrication process of TRAIL-DOX-PM-NV, active targeting property, and inhibition of tumor growth. (A) Schematic illustration of preparation of TRAIL-DOX-PM-NV. (B) Fluorescence distribution of tumors treated with TRAIL-DOX-NV and TRAIL-DOX-PM-NV. Scale bar: 100 µm. (C) Tumor volume following administration of saline, TRAIL-DOX-NV, TRAIL-PM-NV, DOX-PM-NV, and TRAIL-DOX-PM-NV. Reproduced with permission from [107]. Copyright 2015 John Wiley & Sons.